Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Association between colorectal cancer and Fusobacterium nucleatum and Bacteroides fragilis bacteria in Iranian patients: a preliminary study
Aref Shariati, Shabnam Razavi, Ehsanollah Ghaznavi‐Rad, et al.
Infectious Agents and Cancer (2021) Vol. 16, Iss. 1
Open Access | Times Cited: 39

Showing 1-25 of 39 citing articles:

Microbiome-Driven Therapeutics: From Gut Health to Precision Medicine
Muneer Yaqub, Aashika Jain, Chinedu Eucharia Joseph, et al.
Gastrointestinal Disorders (2025) Vol. 7, Iss. 1, pp. 7-7
Open Access | Times Cited: 2
Global prevalence of Fusobacterium nucleatum and Bacteroides fragilis in patients with colorectal cancer: an overview of case reports/case series and meta-analysis of prevalence studies
Fatemeh Sameni, Parisa Abedi Elkhichi, Ali Dadashi, et al.
BMC Gastroenterology (2025) Vol. 25, Iss. 1
Open Access | Times Cited: 2
Enrichment of Prevotella intermedia in human colorectal cancer and its additive effects with Fusobacterium nucleatum on the malignant transformation of colorectal adenomas
Chia‐Hui Lo, Deng‐Chyang Wu, Shu‐Wen Jao, et al.
Journal of Biomedical Science (2022) Vol. 29, Iss. 1
Open Access | Times Cited: 44
Unraveling the Role of Fusobacterium nucleatum in Colorectal Cancer: Molecular Mechanisms and Pathogenic Insights
Linda Galasso, Fabrizio Termite, Irene Mignini, et al.
Cancers (2025) Vol. 17, Iss. 3, pp. 368-368
Open Access | Times Cited: 1
A systemic review of the role of enterotoxic Bacteroides fragilis in colorectal cancer
Nancy E. Scott, Emma Whittle, Patricio Jeraldo, et al.
Neoplasia (2022) Vol. 29, pp. 100797-100797
Open Access | Times Cited: 31
Role of Gut Microbiome in Neoadjuvant Chemotherapy Response in Urothelial Carcinoma: A Multi-institutional Prospective Cohort Evaluation
Laura Bukavina, Rashida Ginwala, Mohamed Eltoukhi, et al.
Cancer Research Communications (2024) Vol. 4, Iss. 6, pp. 1505-1516
Open Access | Times Cited: 6
Fusobacterium nucleatum and Colorectal Cancer
Rongrong Li, Jilu Shen, Yuanhong Xu
Infection and Drug Resistance (2022) Vol. Volume 15, pp. 1115-1120
Open Access | Times Cited: 27
Association of perturbation of oral bacterial with incident of Alzheimer's disease: A pilot study
Majid Taati Moghadam, Nour Amirmozafari, Ali Mojtahedi, et al.
Journal of Clinical Laboratory Analysis (2022) Vol. 36, Iss. 7
Open Access | Times Cited: 24
Evaluation of gut microbiota predictive potential associated with phenotypic characteristics to identify multifactorial diseases
D.C. Fonseca, Ilanna Marques Gomes da Rocha, Bianca Depieri Balmant, et al.
Gut Microbes (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 5
High frequency of enterotoxigenic Bacteroides fragilis and Enterococcus faecalis in the paraffin-embedded tissues of Iranian colorectal cancer patients
Nasibeh Khodaverdi, Habib Zeighami, Ahmad Jalilvand, et al.
BMC Cancer (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 28
The Role of Fecal Fusobacterium nucleatum and pks+ Escherichia coli as Early Diagnostic Markers of Colorectal Cancer
Kaixi Liu, Xinran Yang, Mi Zeng, et al.
Disease Markers (2021) Vol. 2021, pp. 1-11
Open Access | Times Cited: 27
Biosynthesis and bioactivities of microbial genotoxin colibactins
Jianwei Tang, Xin Liu, Wei Ye, et al.
Natural Product Reports (2022) Vol. 39, Iss. 5, pp. 991-1014
Open Access | Times Cited: 19
Evaluation of enterotoxigenic Bacteroides fragilis correlation with the expression of cellular signaling pathway genes in Iranian patients with colorectal cancer
Leila Dadgar-Zankbar, Aref Shariati, Narjess Bostanghadiri, et al.
Infectious Agents and Cancer (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 11
Association of Lactobacillus, Firmicutes, Bifidobacterium, Clostridium, and Enterococcus with colorectal cancer in Iranian patients
Zahra Elahi, Aref Shariati, Narjess Bostanghadiri, et al.
Heliyon (2023) Vol. 9, Iss. 12, pp. e22602-e22602
Open Access | Times Cited: 11
Prevalence of enterotoxigenic Bacteroides fragilis in patients with colorectal cancer: a systematic review and meta-analysis
Shijun Xia, Lijuan Ma, Hui Li, et al.
Frontiers in Cellular and Infection Microbiology (2025) Vol. 15
Open Access
Analysis of changes in microbiome compositions related to the prognosis of colorectal cancer patients based on tissue-derived 16S rRNA sequences
Suk-Jung Choi, Jongsuk Chung, Mi‐La Cho, et al.
Journal of Translational Medicine (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 26
A tale of two bacteria – Bacteroides fragilis, Escherichia coli, and colorectal cancer
Charles Robert Lichtenstern, Reena Lamichhane-Khadka
Frontiers in Bacteriology (2023) Vol. 2
Open Access | Times Cited: 9
Inflammatory bowel disease, colitis, and cancer: unmasking the chronic inflammation link
Vahid Khaze, Saeed Noorolyai, Mahya Ahmadpour Youshanlui, et al.
International Journal of Colorectal Disease (2024) Vol. 39, Iss. 1
Open Access | Times Cited: 3
Association between colorectal cancer and expression levels of miR-21, miR-17-5P, miR-155 genes and the presence of Fusobacterium nucleatum in biopsy samples obtained from Iranian patients
Nazila Bostanshirin, Bahareh Hajikhani, Amir Abbas Vaezi, et al.
Infectious Agents and Cancer (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 7
Exploring the interplay between Fusobacterium nucleatum with the expression of microRNA, and inflammatory mediators in colorectal cancer
Narjess Bostanghadiri, Shabnam Razavi, Aref Shariati, et al.
Frontiers in Microbiology (2023) Vol. 14
Open Access | Times Cited: 7
Harnessing and Mimicking Bacterial Features to Combat Cancer: From Living Entities to Artificial Mimicking Systems
Peng Gao, Zhenyu Duan, Gang Xu, et al.
Advanced Materials (2024) Vol. 36, Iss. 35
Closed Access | Times Cited: 2
Gut microbiota in health and disease: advances and future prospects
Y J Zhang, Hong Wang, Yingpeng Sang, et al.
MedComm (2024) Vol. 5, Iss. 12
Open Access | Times Cited: 2
Diet-mediated gut microbial community modulation and signature metabolites as potential biomarkers for early diagnosis, prognosis, prevention and stage-specific treatment of colorectal cancer
Mutebi John Kenneth, Hsin‐Chi Tsai, Chuan‐Yin Fang, et al.
Journal of Advanced Research (2022) Vol. 52, pp. 45-57
Open Access | Times Cited: 11
Prolonged gut microbial alterations in post‐transplant survivors of allogeneic haematopoietic stem cell transplantation
Akihisa Hino, Kentaro Fukushima, Shinsuke Kusakabe, et al.
British Journal of Haematology (2022) Vol. 201, Iss. 4, pp. 725-737
Closed Access | Times Cited: 10
Molecular determination of O25b/ST131 clone type among extended spectrum β-lactamases production Escherichia coli recovering from urinary tract infection isolates
Amin Khoshbayan, Rezvan Golmoradi Zadeh, Majid Taati Moghadam, et al.
Annals of Clinical Microbiology and Antimicrobials (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 9
Page 1 - Next Page

Scroll to top